Avenue Therapeutics Inc (ATXI)
1.88
-0.07
(-3.59%)
USD |
NASDAQ |
Nov 14, 11:13
Avenue Therapeutics Shareholders Equity (Quarterly): 4.764M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 4.764M |
March 31, 2024 | 2.836M |
December 31, 2023 | 1.582M |
September 30, 2023 | -3.65M |
June 30, 2023 | -5.336M |
March 31, 2023 | -1.452M |
December 31, 2022 | 3.905M |
September 30, 2022 | -0.039M |
June 30, 2022 | 0.598M |
March 31, 2022 | 1.159M |
December 31, 2021 | 3.451M |
September 30, 2021 | -0.16M |
June 30, 2021 | 0.642M |
March 31, 2021 | 1.475M |
December 31, 2020 | 2.359M |
September 30, 2020 | 3.234M |
Date | Value |
---|---|
June 30, 2020 | 4.101M |
March 31, 2020 | 5.773M |
December 31, 2019 | 6.80M |
September 30, 2019 | 11.96M |
June 30, 2019 | 13.90M |
March 31, 2019 | 20.35M |
December 31, 2018 | -0.631M |
September 30, 2018 | 2.794M |
June 30, 2018 | 5.017M |
March 31, 2018 | 9.353M |
December 31, 2017 | 19.38M |
September 30, 2017 | 24.19M |
June 30, 2017 | 27.16M |
March 31, 2017 | -8.904M |
December 31, 2016 | -8.248M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.336M
Minimum
Jun 2023
6.80M
Maximum
Dec 2019
1.686M
Average
1.582M
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
Fortress Biotech Inc | 17.88M |
Checkpoint Therapeutics Inc | -15.75M |
Journey Medical Corp | 11.30M |
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.988M |
Total Liabilities (Quarterly) | 1.161M |